Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Urinary Bladder Neoplasms 1Postoperative Cognitive Complications 1Breast Neoplasms 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Benzodiazepines × Clear all
NCT01298193 2023-03-07

Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.

Spanish Breast Cancer Research Group

Phase 4 Completed
212 enrolled 19 charts
Breast

Breast Neoplasms

NCT03029676 2017-01-24

The Assessment of POCD After TURBT Under Spinal Anesthesia

Medical University of Warsaw

Phase 4 Unknown
200 enrolled
Genitourinary

Postoperative Cognitive Complications, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡